ABT Trading Analysis - 10/21/2026 11:28 AM — TRU-SENTIMENT

News Headlines & Context

The following items are based on general knowledge and are separated from the data-driven analysis below:

• ABBott Laboratories (ABT) recently completed its Q3 2026 earnings call emphasizing steady medical-device demand; shares traded lower post-ex-dividend dated 2026-10-15.
• Management cited continued GLP-1 adjacent infusion-product growth but flagged softer international diagnostics revenue.
• Regulatory news around FDA clearance for a new cardiac monitoring device provided a mild positive catalyst earlier in October 2026.
• Broader healthcare sector rotation and low-beta defensiveness (ABT beta 0.34) kept the stock range-bound versus high-growth peers.

Context: The ex-dividend date and post-earnings drift align with the embedded daily data showing a close of 102.76 on 2026-10-20 after a 105.53 open, while options sentiment turned bearish into 2026-10-21.

Fundamental Analysis

Based strictly on the provided FUNDAMENTALS data for ABT:

• Trailing P/E: 33.20; Trailing EPS: 3.14; Market Cap: $169,542,926,340.40; Shares Out: 1,730,383,000.00
• Dividend Yield: 2.42%; Dividend Rate: 2.52; Ex-Dividend: 2026-10-15; Beta: 0.34
• 52-Week High: 132.03; 52-Week Low: 81.97; Institutional Ownership: 58.71%
• Average Volume: 9,310,000.00; Historical Volatility: 20.34%; Fiscal Year End: 2025-12-01
• Forward PE, PEG, P/B, Revenue, Margins, ROE, D/E, FCF, Target Price: null/not provided

Revenue growth, profit margins, and ROE are not available in the data. The trailing P/E of 33.20 is elevated versus a low-beta defensive profile, but no peer comparison or PEG is supplied. Fundamental strength is evidenced by a 2.42% yield and 58.71% institutional hold; concern is the absent cash-flow and leverage metrics. Fundamentals diverge from the bearish options sentiment but align with the neutral-to-soft technical posture (price below 50-day SMA).

Current Market Position

Current price per indicators: $102.76 (as of 2026-10-20). Minute bars show 2026-10-21 11:00 close at $97.98, down from $105.49 on 2026-10-20 09:30. Recent daily action: 2026-10-20 high 105.62, low 100.75, close 102.76 on volume 10,161,639 (above 20-day avg 5,519,956). Intraday momentum is bearish: last 5 minute bars decline from 99.82 to 97.98 with volume spikes near 626,046 at 10:45.

Technical Analysis

Price is below SMA 50 ($105.68) and SMA 5 ($103.82) but above SMA 20 ($100.98) — mixed alignment, no golden/death cross on given SMAs. RSI 61.94 shows moderate momentum, not overbought. MACD (-0.11) below signal (-0.09), histogram -0.02 = mild bearish. Bollinger: price near mid ($100.98), inside bands, no squeeze. 30-day range $95.06–$106.86; price at $102.76 is ~36% up from low.

True Sentiment Analysis (Delta 40-60 Options)

Options flow (2026-10-21) via tru-sentiment methodology:

Call Volume: $220,905.00 (39.80%) Put Volume: $334,195.00 (60.20%) Total: $555,100.00

Sentiment: Bearish. Contracts: 744 call / 932 put. Pure directional conviction skews bearish via put dominance. Divergence: technicals neutral (RSI 61.94, price above SMA20) yet options bearish — confirmed by spread engine "Divergence detected between technical indicators and options sentiment".

Key Price Levels (Observational Only)